The BCL-2 Family Reunion

Slides:



Advertisements
Similar presentations
The BCL-2 Family Reunion Jerry E. Chipuk, Tudor Moldoveanu, Fabien Llambi, Melissa J. Parsons, Douglas R. Green Molecular Cell Volume 37, Issue 3, Pages.
Advertisements

Restoring cancer's death sentence
The Structure of a Bcl-xL/Bim Fragment Complex
How cells die: Apoptosis pathways
Elodie Pronier, Ross L. Levine  Cancer Cell 
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 45, Issue 6, Pages (March 2012)
Callum Smits, Peter E. Czabotar, Mark G. Hinds, Catherine L. Day 
Volume 12, Issue 2, Pages (August 2007)
The Many Roles of FAS Receptor Signaling in the Immune System
Chaperone-Assisted Crystallography with DARPins
The Structure of a Bcl-xL/Bim Fragment Complex
Volume 108, Issue 6, Pages (March 2002)
Volume 34, Issue 4, Pages (May 2009)
Volume 44, Issue 1, Pages 9-16 (October 2011)
Volume 130, Issue 6, Pages (September 2007)
Joshua E. Allen, Wafik S. El-Deiry  Gastroenterology 
Volume 24, Issue 1, Pages (October 2006)
David R Buckler, Yuchen Zhou, Ann M Stock  Structure 
Lucifer's Labyrinth—Ten Years of Path Finding in Cell Death
James J Chou, Honglin Li, Guy S Salvesen, Junying Yuan, Gerhard Wagner 
Volume 11, Issue 5, Pages (May 2003)
Volume 4, Issue 5, Pages (November 1999)
Volume 55, Issue 6, Pages (September 2014)
Structure of Bax  Motoshi Suzuki, Richard J. Youle, Nico Tjandra  Cell 
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Volume 102, Issue 1, Pages 1-4 (July 2000)
Volume 26, Issue 3, Pages (May 2007)
Crystal Structure of a Y-Family DNA Polymerase in Action
Volume 69, Issue 5, Pages e5 (March 2018)
Volume 28, Issue 6, Pages (December 2007)
Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt- Activated Inhibitory Factor 1  Yuguang Zhao, Tomas Malinauskas, Karl.
Volume 26, Issue 1, Pages e4 (January 2018)
Volume 133, Issue 1, Pages (April 2008)
Volume 20, Issue 1, Pages 9-19 (October 2005)
Volume 90, Issue 1, Pages (July 1997)
Structural Basis for Protein Recognition by B30.2/SPRY Domains
The Chemical Biology of Apoptosis
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Volume 22, Issue 2, Pages (February 2005)
Death upon a Kiss: Mitochondrial Outer Membrane Composition and Organelle Communication Govern Sensitivity to BAK/BAX-Dependent Apoptosis  Thibaud T.
SUMO Takes Control of a Ubiquitin-Specific Protease
Coiled-Coil Domains of SUN Proteins as Intrinsic Dynamic Regulators
Mark Del Campo, Alan M. Lambowitz  Molecular Cell 
Volume 19, Issue 10, Pages (October 2011)
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Dynamics of the BH3-Only Protein Binding Interface of Bcl-xL
Solution Structure of a TBP–TAFII230 Complex
Volume 130, Issue 6, Pages (September 2007)
Arnaud Autret, Seamus J. Martin  Molecular Cell 
Volume 127, Issue 2, Pages (October 2006)
Volume 14, Issue 6, Pages (June 2006)
Robert S. Magin, Glen P. Liszczak, Ronen Marmorstein  Structure 
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Molecular Structures of Transcribing RNA Polymerase I
Jia-Wei Wu, Amy E. Cocina, Jijie Chai, Bruce A. Hay, Yigong Shi 
Solution Structure of the Proapoptotic Molecule BID
Jeffrey C Rathmell, Craig B Thompson  Cell 
Volume 15, Issue 4, Pages (August 2004)
Jean-Claude Martinou, Richard J. Youle  Developmental Cell 
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
“Bak (and Bax) to the Future” — of Primary Melanoma Prognosis?
Brett K. Kaiser, Matthew C. Clifton, Betty W. Shen, Barry L. Stoddard 
Y. Zenmei Ohkubo, Emad Tajkhorshid  Structure 
Insights into Programmed Cell Death through Structural Biology
Structural Basis for Activation of ARF GTPase
The Many Roles of FAS Receptor Signaling in the Immune System
Robert S. Magin, Glen P. Liszczak, Ronen Marmorstein  Structure 
Volume 95, Issue 2, Pages (October 1998)
Presentation transcript:

The BCL-2 Family Reunion Jerry E. Chipuk, Tudor Moldoveanu, Fabien Llambi, Melissa J. Parsons, Douglas R. Green  Molecular Cell  Volume 37, Issue 3, Pages 299-310 (February 2010) DOI: 10.1016/j.molcel.2010.01.025 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 The Mitochondrial Pathway of Apoptosis and the BCL-2 Family (A) Cellular stress causes transcriptional and posttranscriptional regulation of the BCL-2 family to promote MOMP. MOMP is induced by interactions between the BH3-only and effector proteins and leads to cytochrome c release, APAF-1 recruitment, and caspase activation. At the time of MOMP (middle), the intact mitochondrial network (green, left) undergoes fragmentation (gray, right), and soon after the cell is disassembled. The mitochondria in the middle are enlarged from the white box. (B) The BCL-2 family is divided into antiapoptotic, effector, and direct activator/sensitizer/derepressor BH3-only proteins. (C) The antiapoptotic BCL-2 protein binding profiles for the BH3-only proteins. Molecular Cell 2010 37, 299-310DOI: (10.1016/j.molcel.2010.01.025) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 BCL-2 Family Composition and Membrane Permeabilization (A) The BCL-2 proteins are comprised of BCL-2 homology (BH) domains. A representation of an antiapoptotic (BCL-2), effector (BAX), and BH3-only (BID) protein is shown with the BH1-4 designated underneath the corresponding α helices. (B) Proposed model of BAX activation. Soluble BAX interacts with a direct activator and the OMM to promote stable N-terminal exposure, and BAX α5, α6, and α9 insert within the OMM. Molecular Cell 2010 37, 299-310DOI: (10.1016/j.molcel.2010.01.025) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 BH3-Only Protein Function (A) Sensitizer BH3-only protein function. A sensitizer BH3-only protein inhibits the antiapoptotic BCL-2 repertoire. Following minimal cellular stress, a direct activator is induced but cannot be inhibited and MOMP proceeds. (B) Derepressor BH3-only protein function. A direct activator is sequestered by an antiapoptotic BCL-2 protein. Following cellular stress, a derepressor BH3-only protein is induced and competes with the direct activator for binding to the antiapoptotic repertoire. When the direct activator is released, MOMP proceeds. (C) The neutralization model of BCL-2 family function. In this model, BAK/BAX are always competent to promote MOMP but are actively inhibited by the antiapoptotic BCL-2 repertoire to promote survival. Following cellular stress, BH3-only proteins are induced, bind the antiapoptotic proteins, and displace effectors to promote MOMP. Molecular Cell 2010 37, 299-310DOI: (10.1016/j.molcel.2010.01.025) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 Structural Highlights for the BCL-2 Family (A) The “front” view of BCL-xL identifies the BCL-2 core and the respective locations of the four BH regions. The PDB identifier is in parentheses. (B) Surface representation of free BCL-xL, emphasizing amino acids participating in BH3 peptide binding at the “front” face, identifies the BC groove. Representations are partially transparent, permitting identification, beneath the surface, of contact side chains positioned 4 Å from a peptide. With the exception of free BCL-xL and MCL-1 (C), both having surface coloring based on all atoms of peptide amino acids, surface coloring highlights strictly the atoms within 4 Å from a peptide. PDB residue numbering has been maintained. Labels of acidic and basic amino acids are colored red and blue, respectively. (C) Free MCL-1. (D) A1 bound to BIM BH3. The four conserved hydrophobic residues/sites and the conserved charged interactions are marked. Peptide amino acid labels are bold. (E) BCL-xL bound to BIM BH3. (F) MCL-1 bound to BIM BH3. (G) A model between BID BH3 (from the A1·BID BH3 complex) and BAK-ΔTM, overlapping sites of interaction (colored) identified by NMR spectroscopy. (H) BIM SAHB modeling to the “back” face of free BAX. (I) BIM SAHB binding site on BAX. Molecular Cell 2010 37, 299-310DOI: (10.1016/j.molcel.2010.01.025) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 5 Binding of BH3-Only Peptides, Proteins, and ABT-737 to BC Grooves (A) Structure-based alignment of BH3 peptides from complexes with A1 (BAK, 2VOH; BID, 2VOI; BIM, 2VM6; PUMA, 2VOH; BMF, 2VOG), BCL-xL (2BZW, full-length BAD; 2P1L, BECLIN), and MCL-1 (Noxa A, 2ROD; Noxa B, 2NLA; see Table S2). BC grooves accommodate different types of BH3 amino acids: h, hydrophobic; m, mixed; s, small; c, charged. The degree of conservation, illustrated in black (100%), green (>75%), blue (>50%), and yellow (25%), identifies a conserved core defining BH3 peptide specificity. The five conserved hydrophobic residues/sites and the conserved charged interactions are marked. (B) Structure of BCL-xL illustrates overlapping sites of interaction with full-length BAD and ABT-737. Molecular Cell 2010 37, 299-310DOI: (10.1016/j.molcel.2010.01.025) Copyright © 2010 Elsevier Inc. Terms and Conditions